These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30191582)

  • 1. Clinical experience with wearable cardioverter defibrillators at a tertiary electrophysiology program.
    Bossory L; Schubert S; Afzal MR; Weiss R; Tyler J; Kalbfleisch S; Augostini R; Hummel J; Okabe T; Daoud EG; Houmsse M
    Pacing Clin Electrophysiol; 2018 Nov; 41(11):1491-1494. PubMed ID: 30191582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
    Kaspar G; Sanam K; Gholkar G; Bianco NR; Szymkiewicz S; Shah D
    Int J Cardiol; 2018 Dec; 272():179-184. PubMed ID: 30121177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW; Vamos M; Sirat AS; Hohnloser SH
    Clin Res Cardiol; 2017 Apr; 106(4):300-306. PubMed ID: 27888304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B; Reek S; Saguner AM; Krasniqi N; Eriksson U; Duru F
    Swiss Med Wkly; 2019 Nov; 149():w20136. PubMed ID: 31707723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA; Vermilye K; Moss AJ; Goldenberg I; Klein HU; McNitt S; Zareba W; Kutyifa V
    Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
    J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience.
    Singh M; Wang NC; Jain S; Voigt AH; Saba S; Adelstein EC
    J Am Coll Cardiol; 2015 Dec; 66(23):2607-2613. PubMed ID: 26670060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wearable Cardioverter Defibrillator in Nonischemic Cardiomyopathy: A US National Database Analysis.
    Salehi N; Nasiri M; Bianco NR; Opreanu M; Singh V; Satija V; Jhand AS; Karapetyan L; Safadi AR; Surapaneni P; Thakur RK
    Can J Cardiol; 2016 Oct; 32(10):1247.e1-1247.e6. PubMed ID: 26975224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wearable cardioverter-defibrillators: A review of evidence and indications.
    Cheung CC; Olgin JE; Lee BK
    Trends Cardiovasc Med; 2021 Apr; 31(3):196-201. PubMed ID: 32205034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS; Bianco NR; Knilans TK; Czosek RJ; Anderson JB
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006163. PubMed ID: 29945928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD).
    Klein HU; Meltendorf U; Reek S; Smid J; Kuss S; Cygankiewicz I; Jons C; Szymkiewicz S; Buhtz F; Wollbrueck A; Zareba W; Moss AJ
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):353-67. PubMed ID: 19889186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein HU; McNitt S; Zareba W; Goldenberg I
    Pacing Clin Electrophysiol; 2018 Oct; 41(10):1307-1313. PubMed ID: 29992590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Wearable Cardioverter-Defibrillator (WCD)].
    Helms TM; Müller A; Schwab JO; Bänsch D; Karle C; Klingenheben T; Zugck C; Perings C
    Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):129-33. PubMed ID: 25939989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.
    Sasaki S; Shoji Y; Ishida Y; Kinjo T; Tsushima Y; Seno M; Nishizaki F; Itoh T; Izumiyama K; Yokota T; Yokoyama H; Yamada M; Horiuchi D; Kimura M; Higuma T; Tomita H; Okumura K
    J Cardiol; 2017 Jan; 69(1):359-363. PubMed ID: 27595899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.
    Zishiri ET; Williams S; Cronin EM; Blackstone EH; Ellis SG; Roselli EE; Smedira NG; Gillinov AM; Glad JA; Tchou PJ; Szymkiewicz SJ; Chung MK
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):117-28. PubMed ID: 23275233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.